AAAAAA

   
Results: 1-9 |
Results: 9
UNMANIPULATED BLOOD-CELL TRANSPLANTS FROM PARTIALLY MISMATCHED RELATED DONORS
Authors: RUSSELL JA BROWN C RUETHER D STEWART D CHAUDHRY A BOOTH K DESAI S TURNER AR LARRATT L COPPES M KLASSEN J
Citation: Ja. Russell et al., UNMANIPULATED BLOOD-CELL TRANSPLANTS FROM PARTIALLY MISMATCHED RELATED DONORS, Bone marrow transplantation, 21, 1998, pp. 15-15
MATCHED SIBLING BLOOD-CELL TRANSPLANTS - FASTER ENGRAFTMENT BUT PERHAPS MORE CHRONIC GVHD
Authors: RUSSELL JA BROWN C RUETHER D STEWART D CHAUDHRY A BOOTH K DESAI S TURNER AR LARRATT L COPPES M GYONYOR E KLASSEN J
Citation: Ja. Russell et al., MATCHED SIBLING BLOOD-CELL TRANSPLANTS - FASTER ENGRAFTMENT BUT PERHAPS MORE CHRONIC GVHD, Bone marrow transplantation, 21, 1998, pp. 24-24
PARTIALLY MISMATCHED BLOOD-CELL TRANSPLANTS FOR HIGH-RISK HEMATOLOGICMALIGNANCY
Authors: RUSSELL JA DESAI S HERBUT B BROWN C LUIDER J RUETHER JD STEWART D CHAUDHRY A BOOTH K JORGENSON K COPPES MJ TURNER AR LARRATT L POON MC KLASSEN J
Citation: Ja. Russell et al., PARTIALLY MISMATCHED BLOOD-CELL TRANSPLANTS FOR HIGH-RISK HEMATOLOGICMALIGNANCY, Bone marrow transplantation, 19(9), 1997, pp. 861-866
MYASTHENIA-GRAVIS IN ASSOCIATION WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION - CLINICAL OBSERVATIONS, THERAPEUTIC IMPLICATIONS AND REVIEW OF LITERATURE
Authors: MACKEY JR DESAI S LARRATT L CWIK V NABHOLTZ JM
Citation: Jr. Mackey et al., MYASTHENIA-GRAVIS IN ASSOCIATION WITH ALLOGENEIC BONE-MARROW TRANSPLANTATION - CLINICAL OBSERVATIONS, THERAPEUTIC IMPLICATIONS AND REVIEW OF LITERATURE, Bone marrow transplantation, 19(9), 1997, pp. 939-942
RESPONSE-ADAPTED THERAPY OF DE-NOVO ACUTE MYELOBLASTIC-LEUKEMIA (AML)- UPDATE OF A PHASE-II MULTICENTER STUDY OF SEQUENTIAL INDUCTION REGIMENS IDALUBICIN CYTARABINE AND MITOXANTRONE/ETOPOSIDE/
Authors: VANDERJAGT R ROBINSON S GLUCK S BELCH A SHERIDAN D MATTHEWS J LARRATT L MARKMAN S DIPIETRO N PHAM B SHUSTIK C STEWART K
Citation: R. Vanderjagt et al., RESPONSE-ADAPTED THERAPY OF DE-NOVO ACUTE MYELOBLASTIC-LEUKEMIA (AML)- UPDATE OF A PHASE-II MULTICENTER STUDY OF SEQUENTIAL INDUCTION REGIMENS IDALUBICIN CYTARABINE AND MITOXANTRONE/ETOPOSIDE/, Blood, 90(10), 1997, pp. 2264-2264
2ND ALLOGENEIC TRANSPLANTS FOR LEUKEMIA USING BLOOD INSTEAD OF BONE-MARROW AS A SOURCE OF HEMATOPOIETIC-CELLS
Authors: RUSSELL JA BOWEN T BROWN C LUIDER J RUETHER JD STEWART D JORGENSON K COPPES MJ TURNER AR LARRATT L CHAUDHRY A BOOTH K POON MC KLASSEN J
Citation: Ja. Russell et al., 2ND ALLOGENEIC TRANSPLANTS FOR LEUKEMIA USING BLOOD INSTEAD OF BONE-MARROW AS A SOURCE OF HEMATOPOIETIC-CELLS, Bone marrow transplantation, 18(3), 1996, pp. 501-505
ALLOGENEIC BLOOD-CELL TRANSPLANTS FOR HEMATOLOGICAL MALIGNANCY - PRELIMINARY COMPARISON OF OUTCOMES WITH BONE-MARROW TRANSPLANTATION
Authors: RUSSELL JA BROWN C BOWEN T LUIDER J RUETHER JD STEWART D CHAUDHRY A BOOTH K JORGENSON K COPPES MJ TURNER AR LARRATT L DESAI S POON MC KLASSEN J
Citation: Ja. Russell et al., ALLOGENEIC BLOOD-CELL TRANSPLANTS FOR HEMATOLOGICAL MALIGNANCY - PRELIMINARY COMPARISON OF OUTCOMES WITH BONE-MARROW TRANSPLANTATION, Bone marrow transplantation, 17(5), 1996, pp. 703-708
RESPONSE-ADAPTED TREATMENT OF DE-NOVO ACUTE MYELOBLASTIC-LEUKEMIA (AML) - A PHASE-II MULTICENTER STUDY OF SEQUENTIAL INDUCTION REGIMES IDARUBICIN CYTARABINE AND MITOXANTRONE/ETOPOSIDE/
Authors: VANDERJAGT R ROBINSON S GLUCK S BELCH A SHERIDAN D MATTHEWS J LARRATT L MARKMAN S DIPIETRO N PHAM B SHUSTIK C STEWART K
Citation: R. Vanderjagt et al., RESPONSE-ADAPTED TREATMENT OF DE-NOVO ACUTE MYELOBLASTIC-LEUKEMIA (AML) - A PHASE-II MULTICENTER STUDY OF SEQUENTIAL INDUCTION REGIMES IDARUBICIN CYTARABINE AND MITOXANTRONE/ETOPOSIDE/, Blood, 86(10), 1995, pp. 2051-2051
A PHASE-II MULTICENTER STUDY OF SEQUENTIAL, RESPONSE-ADAPTED INDUCTION REGIMENS IDARUBICIN CYTARABINE AND MITOXANTRONE ETOPOSIDE, FOR TREATMENT OF DE-NOVO AML
Authors: VANDERJAGT R ROBINSON S GLUCK S SHERIDAN D MATHEWS J BELCH A LARRATT L MARKMAN S SHUSTIK C HO AD
Citation: R. Vanderjagt et al., A PHASE-II MULTICENTER STUDY OF SEQUENTIAL, RESPONSE-ADAPTED INDUCTION REGIMENS IDARUBICIN CYTARABINE AND MITOXANTRONE ETOPOSIDE, FOR TREATMENT OF DE-NOVO AML, Blood, 84(10), 1994, pp. 10000304-10000304
Risultati: 1-9 |